Yıl 2015, Cilt: 8 Sayı : 1 Sayfalar 85 - 94 2015-06-01
Bioavailability and Bioequivalence
Biyoyararlanım ve Biyoeşdeğerlik#
Güliz ÇELİK,Yavuz Osman BİRDANE
62 261

At the present days, developments in the pharmaceutical industry ans technological progression continues to increase. The Pharmaceutical products which are sold a lot, are marketed under different names by pharmaceutical companies. Thus, containing the same active ingredient in the same amount is increasing rapidly the number of similar preparations on the market. The similar products which are same active ingredient in the same amount must be equivalent to each other to be pharmaceutically bioequivalent. Drugs should be effective, safe, affordable and acceptable cost. The amount of drugs which reach from application area to target area, is important. This means is bioavailability. The bioavailability is the most important factor on the medication treatment applications. Whether obtain the therapeutic response of systemically active drugs is determined by bioavailability studies. Therefore, the health authorities which permit to production and sale of drugs, want to prove generic drugs to be bioequivalent to the original drug. To get better quality, cheaper and safer drugs will be possible with bioavailability and bioequivalence studies

Anahtar Kelimeler

Anonymous. Guidelines fort he Conduct of Bioequivalence Studies for Veterinary Medicinal Product. The European Agency fort he Evaluation of Medicinal Products Veterinary Medicines and Information Technology. Committee for Veterinary Medicinal Product. EMEA/CVMP/016/00-corr-FINAL.2001;
Birincil Dil
Konular Fen
Yayımlanma Tarihi 1 Haziran 2015

Yayımlanma Tarihi : 1 Haziran 2015

Makalenin Yazarları
Yavuz Osman BİRDANE